Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Cosmos Health Inc. (COSM)

0.3050 +0.0151 (+5.21%)
As of 1:53:26 PM EST. Market Open.
Chart Range Bar
Loading chart for COSM
  • Previous Close 0.2899
  • Open 0.2901
  • Bid 0.2860 x 100
  • Ask 0.5000 x 300
  • Day's Range 0.2900 - 0.3052
  • 52 Week Range 0.1620 - 0.8200
  • Volume 813,871
  • Avg. Volume 3,042,854
  • Market Cap (intraday) 30.693M
  • Beta (5Y Monthly) 4.44
  • PE Ratio (TTM) --
  • EPS (TTM) -0.6500
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 2.95

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece.

www.cosmoshealthinc.com

163

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

COSM
38.76%
S&P 500 (^GSPC)
8.21%

1-Year Return

COSM
54.68%
S&P 500 (^GSPC)
10.22%

3-Year Return

COSM
71.50%
S&P 500 (^GSPC)
69.66%

5-Year Return

COSM
91.95%
S&P 500 (^GSPC)
57.69%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 18.99M
Earnings -6.09M
Profit Margin -32.06%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

-10M
0
10M
-50.0%
-40.0%
-30.0%
-20.0%
-10.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

1.40
2.95 Average
0.3050 Current
4.50 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -33.08%

  • Return on Assets (ttm)

    -18.42%

  • Return on Equity (ttm)

    -104.00%

  • Revenue (ttm)

    73.73M

  • Net Income Avi to Common (ttm)

    -24.39M

  • Diluted EPS (ttm)

    -0.6500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.84M

  • Total Debt/Equity (mrq)

    77.28%

  • Levered Free Cash Flow (ttm)

    -10.07M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: